Journals / Van Tıp Dergisi / 2016 / Cilt: 23 - Sayı: 4

Yeni Platelet Belirteçleri ve Kalsifik Aort Darlığı Arasındaki İlişki: Plateletkrit ve Platelet Lenfosit Oranı

Association between New Platelet Indices and Calcific Aortic Stenosis: Plateletcrit and Platelet to Lymphocyte Ratio

Pages
330–337
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: PCT and PLR, which reflect elevated inflammatory status and platelet activation and aggregation, are useful, cheap, easily available and simply calculated markers that have an ability to improve risk stratification of patients with calcific AS for treatment strategies.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Calcific aortic stenosis (AS) is the leading cause of death from valvular heart disease in worldwide.
📊
Key Findings & Data:Materials and Methods: A total of 98 consecutive patients diagnosed with calcific AS and 30 healthy controls were included in this retrospective study.
💡
Conclusion & Impact:Conclusion: PCT and PLR, which reflect elevated inflammatory status and platelet activation and aggregation, are useful, cheap, easily available and simply calculated markers that have an ability to improve risk stratification of patients with calcific AS for treatment strategies.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Calcific aortic stenosis (AS) is the leading cause of death from valvular heart disease in worldwide. We aimed to evaluate the relationship between plateletcrit (PCT), platelet to lymphocyte ratio (PLR) and presence and severity of the calcific AS in the present study. Materials and Methods: A total of 98 consecutive patients diagnosed with calcific AS and 30 healthy controls were included in this retrospective study. Patients with calcific AS were divided into three groups according to severity of disease as follows: mild AS (n=35), moderate AS (n=30) and severe AS (n=33). Results: PCT and PLR were demonstrated to be significantly higher in the AS. Moreover, PCT and PLR were significantly highest in the severe AS group than in the mild and moderate AS groups. Correlation analysis indicated positive significant relationships between the PCT and maximal and mean transaortic gradients, and maximum jet velocities; but negative association with AVA. The same relations were obtained between PLR and echocardiographic parameters of severity of AS. Conclusion: PCT and PLR, which reflect elevated inflammatory status and platelet activation and aggregation, are useful, cheap, easily available and simply calculated markers that have an ability to improve risk stratification of patients with calcific AS for treatment strategies.

Özet

Amaç: Kalsifik aort darlığı (AD) dünyada kalp kapak hastalıklarından ölümlerin önde gelen nedenidir. Biz bu çalışmada plateletkrit (PKT) ve platelet lenfosit oranı (PLO) ile kalsifik AD'nın varlığı ve şiddeti ile olan ilişkisini incelemeyi amaçladık. Gereç ve Yöntem: Bu retrospektif çalışmaya sırasıyla 98 kalsifik AD tanısı olan hasta ile 30 sağlıklı kontrol dahil edildi. Kalsifik AD hastaları hastalığın şiddetine göre 3 gruba şu şekilde ayrıldı: hafif AD (n=35), orta AD (n=30) ve ileri AD (n=33). Bulgular: PKT ve PLO aort darlığı grubunda anlamlı derecede yüksek bulundu. Ayrıca, PKT ve PLO ileri AD grubunda hafif ve orta AD gruplarına göre önemli derecede en yüksek saptandı. Korelasyon analizinde PKT ile maksimum ve ortalama transaortik gradyan ve maksimum jet akım hızı arasında önemli pozitif, aort kapak alanı ile anlamlı negatif ilişki saptandı. Benzer ilişkiler PLO ile AD şiddetinin ekokardiyografik parametreleri ile gösterildi. Sonuç: Artmış inflamatuar durum ve platelet aktivasyon ve agregasyonunu yansıtan PKT ve PLO kalsifik AD olan hastalarda tedavi stratejileri için risk sınıflamasını iyileştirebilen kullanışlı, kolay elde edilebilen, ucuz ve basit hesaplanabilir belirteçlerdir.

🔖

Cite This Article

ÇAKMAK, H. A., ENHOŞ, A., ERTÜRK, M., KALKAN, A. K., SATILMIŞOĞLU, M. H., GÜL, M. (2016). Yeni Platelet Belirteçleri ve Kalsifik Aort Darlığı Arasındaki İlişki: Plateletkrit ve Platelet Lenfosit Oranı. Van Tıp Dergisi, Cilt: 23 - Sayı: 4, 330–337. https://ajindex.com/articles/334559

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Tziomalos K, Athyros VG, Karagiannis A, Mikhailidis DP. Established and emerging vascular risk factors and the development of aortic stenosis: An opportunity for prevention? Expert Opin Ther Targets 2008; 12(7): 809-820.
  2. Rajamannan NM, Evans FJ, Aikawa E, Grande- Allen KJ, Demer LL, Heistad DD, et al. Calcific aortic valve disease: Not simply a degenerative process: A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease - 2011 update. Circulation 2011; 124(16): 1783-1791.
  3. Holme PA, Orvim U, Hamers MJ, Solum NO, Brosstad FR, Barstad RM, et al. Shear-induced platelet activation and platelet microparticle formation at blood flow conditions as in arteries with a severe stenosis. Arterioscler Thromb Vasc Biol 1997; 17(4): 646-653.
  4. Prohaska W, Zittermann A, Lüth JU, Inoue K, Köster-Eiserfunke W, Baller D, et al. Prevalent platelet dysfunction in patients with aortic valve disease. J Heart Valve Dis 2008; 17(5): 542-547.
  5. Fazio G, Caracciolo C, Barone R, D'angelo L, Di Maggio R, Vernuccio F, et al. An unknown cause of aortic valve stenosis: polycythemia vera. J Thromb Thrombolysis 2013; 35(2): 282-285.
  6. Gul M, Uyarel H, Akgul O, Akkaya E, Surgit O, Cakmak HA, et al. Long-term prognostic significance of admission plateletcrit values in patients with non-ST elevation myocardial infarction. Blood Coagul Fibrinolysis 2016.
  7. Article In Press.
  8. Akin F, Ayca B, Kose N, Altun I, Avsar M, Celik O, et al. Relation of platelet indices to severity of coronary artery disease in patients undergoing primary percutaneous coronary intervention. Perfusion 2015. pii: 0267659115594231. Article In Press.
  9. Uğur M, Ayhan E, Bozbay M, Çiçek G, Ergelen M, Işık T, et al. The independent association of plateletcrit with long-term outcomes in patients undergoing primary percutaneous coronary intervention. J Crit Care 2014; 29(6): 978-981.
  10. Oylumlu M, Oylumlu M, Yuksel M, Dogan A, Cakici M, Ozgeyik M, et al. The usefulness of plateletcrit to predict cardiac syndrome X in patients with normal coronary angiogram. Postepy Kardiol Interwencyjnej 2015; 11(3): 197- 201. Akpinar I, Sayin MR, Gursoy YC, Aktop Z, Karabag T, Kucuk E, et al. Plateletcrit and red cell distribution width are independent predictors of the slow coronary flow phenomenon. J Cardiol 2014; 63(2): 112-118.
  11. Akpinar I, Sayin MR, Gursoy YC, Karabag T, Kucuk E, Buyukuysal MC, et al. Plateletcrit: a platelet marker associated wit